Ruth Vera-García

21PUBLICATIONS
95CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 17, 2026
Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study.

|Jul 16, 2026
Economic burden of recurrence in patients with hepatocellular carcinoma after curative-intent treatment in Spain.

|Aug 09, 2025
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry.

Carlos López-López, Eva Martínez de Castro, Ana Fernández Montes

|Jul 19, 2024
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.

Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio

|Oct 04, 2023
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.

Virginia Arrazubi, Saioa Goñi, Iranzu González-Borja

|Jun 28, 2023
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.

Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio

Pageof 4

Frequent Collaborators

6 joint publications

Ana Isabel Bocanegra

6 joint publications

Hugo Arasanz

5 joint publications

Luisa Chocarro

5 joint publications

David Escors